Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

All MBC

• • A Personalized Medicine Study for Patients With Metastatic Breast Cancer (SMMART, Basket Study)
  • FPA150 and Pembrolizumab for Advanced Breast Cancer
  • LY3381916 Alone or With LY3300054 in Metastatic Breast Cancer

Triple-Negative

• • ABBV-927 and ABBV-368 for Advanced Triple Negative Breast Cancer
  • Avelumab With Binimetinib, Utomilumab, or PF-04518600 For Advanced Triple Negative Breast Cancer
  • Capivasertib & Paclitaxel as First-Line Treatment for Advanced Triple Negative Tumors
  • Estradiol in Advanced Triple Negative Tumors that Test Positive for ER Beta
  • Immunotherapy INCAGN02385 in Advanced Triple Negative Breast Cancer
  • Immunotherapy DKY709 Alone or With PDR001 in Advanced Triple Negative Breast Cancer
  • LY3023414 Followed by Prexasertib in Metastatic Triple Negative Breast Cancer
  • TPST-1120 Alone or With a Systemic Therapy in Advanced Triple Negative Breast Cancer
  • TT-00420 For Advanced Triple Negative Breast Cancer

HER2 Positive (HER2+)

• • T-DM1 and Tucatinib for Advanced HER2+ Breast Cancer

Others

• • Satoreotide Trizoxetan PET/CT and Satoreotide Tetraxetan in SSTR2+ Advanced Breast Cancer
  • Hyperthermia and Olaparib for Breast Cancer That Has Come Back in the Chest Wall

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.